On Wednesday, Shares of Sirius XM Holdings Inc. (NASDAQ:SIRI), gained 1.32% to $3.83.
Sirius XM, declared that it will be the exclusive national radio broadcaster for the U.S. Open Championship, and will offer listeners nationwide expanded coverage of this year’s event, taking place at Chambers Bay in University Place, Washington from June 18th through the 21st.
SiriusXM’s programming will feature more than 35 hours of live hole-by-hole coverage – more than has ever been aired before – across all four days of championship play, counting a possible Monday playoff. SiriusXM’s Brian Katrek will anchor the play-by-play broadcast with former PGA Tour pro Mark Carnevale serving as the analyst in the booth. A team of roving reporters, featuring veteran broadcasters and Tour pros - Fred Albers, John Maginnes, Dennis Paulson and Bill Rosinksi - will provide live commentary from around the course.
Joining SiriusXM’s broadcast team for the first time will be former PGA Tour pro Mark Lye, who will serve as an analyst on SiriusXM’s pre-round show on Thursday and Friday alongside Taylor Zarzour and Carl Paulson.
Sirius XM Holdings Inc., through its auxiliaries, provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, counting various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news.
Shares of Merck & Co. Inc. (NYSE:MRK), inclined 1.31% to $59.16, during its last trading session.
Merck & Co., known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. recently declared that pivotal Phase 3 clinical studies of SB4, an investigational biosimilar of Enbrel (etanercept), and SB2, an investigational biosimilar of Remicade (infliximab), met their primary endpoints, demonstrating equivalence to the originator medicine in patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate therapy. The primary endpoint in the two studies was the American College of Rheumatology 20 percent response criteria (ACR20), at week 24 and at week 30 of treatment, respectively. In these studies, SB4 and SB2 demonstrated a safety profile equivalent to the originator medicines.
These results will be presented for the first time at the European League Against Rheumatism (EULAR) 16th annual meeting in Rome, June 10-13.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
Finally, Sears Holdings Corporation (NASDAQ:SHLD), ended its last trade with -19.37% loss, and closed at $29.52.
Sears Holdings Corporation, declared that Seritage Growth Properties has commenced a rights offering for at least 53,298,899 Class A common shares of Seritage following a Registration Statement on Form S-11filed with the Securities and Exchange Commission. The SEC declared the Registration Statement effective on June 9, 2015.
Under the terms of the rights offering, Sears Holdings is distributing to its stockholders, at no charge, one transferable subscription right for every share of Sears Holdings common stock held of record as of 5:00 p.m., New York City time, on June 11, 2015, the formerly declared record date. Each subscription right entitles the holder thereof to purchase one half of one common share of Seritage for each share of Sears Holdings common stock owned as of the record date at a purchase price of $29.58 per whole share. In addition to being able to purchase their pro rata portion of the shares offered based on their ownership as of the record date for the rights offering, Sears Holdings stockholders may oversubscribe for additional Seritage common shares as described in the Registration Statement.
The proceeds from the rights offering will be used to fund a portion of the purchase price for the acquisition from Sears Holdings of 235 Sears- and Kmart-branded stores and Sears Holdings’ 50% interests in joint ventures with each of Simon Property Group, Inc., General Growth Properties, Inc. and The Macerich Company, which joint ventures collectively hold an additional 31 properties.
Sears Holdings Corporation operates as a retailer in the United States. It operates in two segments, Kmart and Sears Domestic. The Kmart segment operates retail stores that offer a range of products, counting consumer electronics, seasonal merchandise, outdoor living, toys, lawn and garden equipment, food and consumables, and apparel; and in-store pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
